Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,657,132 papers from all fields of science
Search
Sign In
Create Free Account
acquired hemophilia
Known as:
acquired haemophilia
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors
M. Shima
,
K. Nogami
,
+5 authors
M. Taki
Haemophilia : the official journal of the World…
2019
Corpus ID: 202569375
Emicizumab is a recombinant humanized bispecific monoclonal antibody mimicking the cofactor function of activated factor VIII.
Highly Cited
2016
Highly Cited
2016
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic‐guided prophylaxis
L. Valentino
,
S. Pipe
,
+6 authors
G. Spotts
Haemophilia : the official journal of the World…
2016
Corpus ID: 13848339
We previously showed that pharmacokinetic‐guided prophylaxis (PKP) allows the dosing interval to be extended while maintaining a…
Expand
Highly Cited
2013
Highly Cited
2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
L. Du
,
P. Nurden
,
+13 authors
D. Wilcox
Nature communications
2013
Corpus ID: 16284494
It is essential to improve therapies for controlling excessive bleeding in patients with haemorrhagic disorders. As activated…
Expand
Review
2012
Review
2012
Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
S. Zappa
,
M. McDaniel
,
J. Marandola
,
G. Allen
Haemophilia : the official journal of the World…
2012
Corpus ID: 1740210
Summary. Frequent evaluation of haemophilia treatment is necessary to improve patient care. The 2010 Practice Patterns Survey…
Expand
Review
2007
Review
2007
Current use of by‐passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors
J. Astermark
,
A. Rocino
,
+8 authors
J. Windyga
Haemophilia : the official journal of the World…
2007
Corpus ID: 39501256
Summary. The ultimate goal of treatment for patients with inhibitory antibodies should be to permanently eradicate the inhibitor…
Expand
Highly Cited
2005
Highly Cited
2005
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.
H. Zeitler
,
G. Ulrich-Merzenich
,
+5 authors
H. Brackmann
Blood
2005
Corpus ID: 10571492
Acquired hemophilia (AH) is an extremely rare condition in which autoantibodies (inhibitors) against clotting factor VIII induce…
Expand
Highly Cited
2005
Highly Cited
2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical…
W. Kreuz
,
J. Gill
,
+5 authors
P. Larson
Thrombosis and haemostasis
2005
Corpus ID: 25099670
The safety and efficacy of a full-length sucrose-formulated recombinant factor VIII product (rFVIII-FS; Kogenate FS; Kogenate…
Expand
2003
2003
Acquired haemophilia in HIV negative, HHV‐8 positive multicentric Castleman's disease: a case report
M. Marietta
,
S. Pozzi
,
+4 authors
G. Torelli
European journal of haematology
2003
Corpus ID: 36968748
Abstract: Multicentric Castleman's Disease (MCD) is an atypical lymphoproliferative disorder, related to human herpesvirus 8 (HHV…
Expand
Highly Cited
1998
Highly Cited
1998
When should prophylactic treatment in patients with haemophilia A and B start?— The German experience
C. Lee
,
C. Kessler
,
+7 authors
B. Kornhuber
Haemophilia : the official journal of the World…
1998
Corpus ID: 20202567
Summary. Radiological and orthopaedic outcome in severe and moderate haemophilia A and B patients undergoing long‐term…
Expand
Highly Cited
1991
Highly Cited
1991
Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene
J. Naylor
,
P. Green
,
A. Montandon
,
F. Giannelli
,
C. Rizza
The Lancet
1991
Corpus ID: 2822920
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE